| Cell-autonomous Cxcl1 sustains tolerogenic circuitries and stromal inflammation via neutrophil-derived TNF in pancreatic cancer A Bianchi, I De Castro Silva, NU Deshpande, S Singh, S Mehra, ... Cancer discovery 13 (6), 1428-1453, 2023 | 37 | 2023 |
| Racial disparity in 30-day outcomes of metabolic and bariatric surgery H Amirian, A Torquati, P Omotosho Obesity Surgery 30, 1011-1020, 2020 | 31 | 2020 |
| Identification of novel early pancreatic cancer biomarkers KIF5B and SFRP2 from “first contact” interactions in the tumor microenvironment HK Charles Jacob, R Signorelli, JL Charles Richard, T Kashuv, S Lavania, ... Journal of Experimental & Clinical Cancer Research 41 (1), 258, 2022 | 13 | 2022 |
| Racial disparity between Whites and African Americans in incidence and outcome of pancreatic cancer: have we made a difference? H Amirian, D Kwon, SM Vickers, A Livingstone, D Jayaweera, AK Saluja, ... Gastroenterology 162 (4), 1346-1348. e3, 2022 | 4 | 2022 |
| Tumor Cell–Intrinsic p38 MAPK Signaling Promotes IL1α-Mediated Stromal Inflammation and Therapeutic Resistance in Pancreatic Cancer SP Singh, AR Dosch, S Mehra, I De Castro Silva, A Bianchi, VT Garrido, ... Cancer Research 84 (8), 1320-1332, 2024 | 2 | 2024 |
| Cell-specific nanoengineering strategy disrupts tolerogenic signaling from myeloid-derived suppressor cells to invigorate antitumor immunity in pancreatic cancer NU Deshpande, A Bianchi, H Amirian, I De Castro Silva, CI Rafie, ... bioRxiv, 2024.05. 25.594901, 2024 | 1 | 2024 |
| Transmembrane TNF-TNFR2 signaling as a critical immunoregulatory node in pancreatic cancer EM Dickey, A Bianchi, H Amirian, PJ Hosein, D Faustman, R Brambilla, ... Oncoimmunology 13 (1), 2326694, 2024 | | 2024 |
| Su1179 MICROBIAL METABOLITE UROLITHIN A REDUCES INFLAMMATION AND ENHANCES GUT BARRIER FUNCTION IN KRASG12D INHIBITOR MRTX1133-TREATED MOUSE MODELS OF PANCREATIC CANCER V Krishnamoorthy, S Mehra, S Jinka, H Amirian, EW Box, S Singh, ... Gastroenterology (New York, NY 1943) 166 (5), S-686-S-686, 2024 | | 2024 |
| Improving patient stratification and selection for curative-intent treatment in localized pancreatic cancer MP Martos, H Amirian, EM Dickey, EW Box, NB Merchant, PJ Hosein, ... Hepatobiliary Surgery and Nutrition 13 (2), 325, 2024 | | 2024 |
| CREB-ROCK driven extracellular matrix remodeling exasperates pancreatic cancer progression S Jinka, S Mehra, V Krishnamoorthy, A Bianchi, K Rajkumar, A Adams, ... Cancer Research 84 (6_Supplement), 4277-4277, 2024 | | 2024 |
| Patient Selection and Outcomes with Hepatic Artery Infusion Chemotherapy (HAIC) in Unresectable Colorectal Liver Metastasis (uCRLM) at a Tertiary Referral Center EM Dickey, KL Koch, H Amirian, F Alessandrino, J Kronenfeld, IDC Silva, ... ANNALS OF SURGICAL ONCOLOGY 31 (1), S204-S204, 2024 | | 2024 |
| Disrupting TNFR2 Signaling Improves Chemotherapy sensitivity in Pancreatic Cancer H Amirian, Bianc-, Anna, I, K Rajkumar, A-am, Andrew, IDC Silva, ... ANNALS OF SURGICAL ONCOLOGY 31 (1), S29-S29, 2024 | | 2024 |
| JNK inhibition reprograms the tumor-immune-microenvironment to overcome chemoresistance in PDAC EW Box III, S Singh, VT Garrido, S Mehra, H Amirian, EM Dickey, ... ANNALS OF SURGICAL ONCOLOGY 31 (1), S61-S62, 2024 | | 2024 |
| A novel mechanism of immunotherapy sensitivity following platinum chemotherapy resistance in pancreatic cancer patients with germline homologous recombination deficiency I Ogobuiro, K Rajkumar, A Bianchi, L Caeiro, H Amirian, L Nivelo, ... ANNALS OF SURGICAL ONCOLOGY 31 (1), S24-S25, 2024 | | 2024 |
| Abstract C064: Chronic platinum exposure induces cell-intrinsic type1 interferon/STING pathway activation in homologous recombination-deficient pancreatic cancer to drive … I Ogobuiro, A Bianchi, L Caeiro, H Amirian, L Nivelo, I De Castro Silva, ... Cancer Research 84 (2_Supplement), C064-C064, 2024 | | 2024 |
| Abstract C021: Granulocytic MDSC-derived NLRP3 inflammasome activation is a novel regulator of inflammatory CAF skewness in pancreatic cancer K Rajkumar, NU Deshpande, I de Castro Silva, A Bianchi, I Ogobuiro, ... Cancer Research 84 (2_Supplement), C021-C021, 2024 | | 2024 |
| Abstract C025: Fibroblast-specific IL1R1-p38 MAPK signaling sustains stromal inflammation and contributes to therapeutic resistance in pancreatic cancer SP Singh, AR Dosch, S Mehra, I de Castro Silva, VT Garrido, A Bianchi, ... Cancer Research 84 (2_Supplement), C025-C025, 2024 | | 2024 |
| Abstract PR16: Neutrophil-intrinsic tumor necrosis factor (TNF) is a novel driver of T-cell and cancer-associated fibroblast (CAF) dysfunction in pancreatic cancer A Bianchi, H Amirian, I De Castro Silva, I Ogobuiro, K Rajkumar, ... Cancer Research 84 (2_Supplement), PR16-PR16, 2024 | | 2024 |
| Neutrophil-intrinsic tumor necrosis factor (TNF) is a novel driver of T-cell and cancer-associated fibroblast (CAF) dysfunction in pancreatic cancer A Bianchi, H Amirian, IDC Silva, I Ogobuiro, K Rajkumar, AM Adams, ... CANCER RESEARCH 84 (2), 2024 | | 2024 |
| Chronic platinum exposure induces cell-intrinsic type1 interferon/STING pathway activation in homologous recombination-deficient pancreatic cancer to drive sensitivity to … I Ogobuiro, A Bianchi, L Caeiro, H Amirian, L Nivelo, IDC Silva, ... CANCER RESEARCH 84 (2), 2024 | | 2024 |
